Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Ali Manouchehrinia"'
Autor:
Tim Spelman, Melinda Magyari, Helmut Butzkueven, Anneke Van Der Walt, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Dana Horáková, Jirí Drahota, Fabio Pellegrini, Robert Hyde, Pierre Duquette, Jeannette Lechner-Scott, Seyed Aidin Sajedi, Patrice Lalive, Vahid Shaygannejad, Serkan Ozakbas, Sara Eichau, Raed Alroughani, Murat Terzi, Marc Girard, Tomas Kalincik, Francois Grand'Maison, Olga Skibina, Samia J. Khoury, Bassem Yamout, Maria Jose Sa, Oliver Gerlach, Yolanda Blanco, Rana Karabudak, Celia Oreja-Guevara, Ayse Altintas, Stella Hughes, Pamela McCombe, Radek Ampapa, Koen de Gans, Chris McGuigan, Aysun Soysal, Julie Prevost, Nevin John, Jihad Inshasi, Leszek Stawiarz, Ali Manouchehrinia, Lars Forsberg, Finn Sellebjerg, Anna Glaser, Luigi Pontieri, Hanna Joensen, Peter Vestergaard Rasmussen, Tobias Sejbaek, Mai Bang Poulsen, Jeppe Romme Christensen, Matthias Kant, Morten Stilund, Henrik Mathiesen, Jan Hillert, The Big MS Data Network: a collaboration of the Czech MS Registry, the Danish MS Registry, Italian MS Registry, Swedish MS Registry, MSBase Study Group, and OFSEP
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundTreatment switching is a common challenge and opportunity in real-world clinical practice. Increasing diversity in disease-modifying treatments (DMTs) has generated interest in the identification of reliable and robust predictors of treatme
Externí odkaz:
https://doaj.org/article/3d52ca1fdc794fa48cba7a9cc328885d
Autor:
Richard Nicholas, Jeff Rodgers, James Witts, Annalaura Lerede, Tim Friede, Jan Hillert, Lars Forsberg, Anna Glaser, Ali Manouchehrinia, Ryan Ramanujam, Tim Spelman, Pernilla Klyve, Jiri Drahota, Dana Horakova, Hanna Joensen, Luigi Pontieri, Melinda Magyari, David Ellenberger, Alexander Stahmann, Helmut Butzkueven, Anneke Van Der Walt, Vladimir Bezlyak, Carol Lines, Rod Middleton
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Introduction: Prescribing guidance for disease-modifying treatment (DMT) in multiple sclerosis (MS) is centred on a clinical diagnosis of relapsing–remitting MS (RRMS). DMT prescription guidelines and monitoring vary across countries. Standardising
Externí odkaz:
https://doaj.org/article/94019eea78bf46cdb31bf422481b6086
Autor:
Kamila Zondra Revendova, Chiara Starvaggi Cucuzza, Ali Manouchehrinia, Mohsen Khademi, Michal Bar, David Leppert, Elisabeth Sandberg, Russell Ouellette, Tobias Granberg, Fredrik Piehl
Publikováno v:
Brain and Behavior, Vol 13, Iss 1, Pp n/a-n/a (2023)
Abstract Background Neurofilament light (NfL) levels reflect inflammatory disease activity in multiple sclerosis (MS), but it is less clear if NfL also can serve as a biomarker for MS progression in treated patients without relapses and focal lesion
Externí odkaz:
https://doaj.org/article/20c0b2d7dd214ee28b9e64e30ad63797
Autor:
Mohammed Alrouji, Ali Manouchehrinia, Jehan Aram, Abdulmajeed Alotaibi, Sharif Alhajlah, Yasir Almuhanna, Othman Alomeir, Anas Shamsi, Bruno Gran, Cris S. Constantinescu
Publikováno v:
Brain Sciences, Vol 13, Iss 5, p 800 (2023)
Objectives: The present study is aimed at determining the effect of cigarette smoking (CS) on serum uric acid (UA) levels quantitatively before and after smoking cessation among people with MS (pwMS). Additionally, a possible correlation between UA l
Externí odkaz:
https://doaj.org/article/644c21cc91d0469bba49f3cf185684e5
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Multiple sclerosis (MS) patients with immunoglobulin gamma (IgG) oligoclonal bands (OCB) in the cerebrospinal fluid (CSF) have different genetic backgrounds and brain MRI features compared to those without. In this study, we aimed to determi
Externí odkaz:
https://doaj.org/article/01d6be95c1a141ee8ecd58413c1b49a1
Autor:
Ali Manouchehrinia, Jesse Huang, Jan Hillert, Lars Alfredsson, Tomas Olsson, Ingrid Kockum, Cris S. Constantinescu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Tobacco smoke is an important modifiable environmental risk factor for multiple sclerosis (MS) risk. The population attributable fraction (AF) of MS due to smoking can be used to assess the contribution of smoking to the risk of MS development. We co
Externí odkaz:
https://doaj.org/article/843164962253481d9e560fd09845994a
Autor:
Ali Manouchehrinia, Fredrik Piehl, Jan Hillert, Jens Kuhle, Lars Alfredsson, Tomas Olsson, Ingrid Kockum
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 1, Pp 139-143 (2020)
Abstract Blood Neurofilament light chain (NfL) has been suggested as a promising biomarker in several neurological conditions. Since blood NfL is the consequence of leaked NfL from the cerebrospinal fluid, differences in individuals’ Body Mass Inde
Externí odkaz:
https://doaj.org/article/ce6db1d4bf8a42a5805089cea268995d
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Purpose: Observational studies have suggested a protective effect of alcohol intake with autoimmune disorders, which was not supported by Mendelian randomization (MR) analyses that used only a few (
Externí odkaz:
https://doaj.org/article/4e6503d42cba4817a6c6dc1f1f9b282b
Autor:
Jan Hillert, Melinda Magyari, Per Soelberg Sørensen, Helmut Butzkueven, Anneke Van Der Welt, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Fabio Pellegrini, Robert Hyde, Leszek Stawiarz, Ali Manouchehrinia, Tim Spelman
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Although over a dozen disease modifying treatments (DMTs) are available for relapsing forms of multiple sclerosis (MS), treatment interruption, switching and discontinuation are common challenges. The objective of this study was to descri
Externí odkaz:
https://doaj.org/article/7b575aa03c2940f0b421f060c9883e06
Autor:
Sahl Khalid Bedri, Ola B Nilsson, Katharina Fink, Anna Månberg, Carl Hamsten, Burcu Ayoglu, Ali Manouchehrinia, Peter Nilsson, Tomas Olsson, Jan Hillert, Hans Grönlund, Anna Glaser
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217208 (2019)
Multiple sclerosis (MS) treatment options have improved significantly over the past decades, but the consequences of MS can still be devastating and the needs for monitoring treatment surveillance are considerable. In the current study we used affini
Externí odkaz:
https://doaj.org/article/9948a069309947b6b9fb8777fc4aebd8